✦ LIBER ✦

Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases

✍ Scribed by Beckers, Thomas; Mahboobi, Siavosh; Sellmer, Andreas; Winkler, Matthias; Eichhorn, Emerich; Pongratz, Herwig; Maier, Thomas; Ciossek, Thomas; Baer, Thomas; Kelter, Gerhard; Fiebig, Heinz-Herbert; Schmidt, Mathias

Book ID: 120429467
Publisher: The Royal Society of Chemistry
Year: 2012
Tongue: English
Weight: 488 KB
Volume: 3
Category: Article
ISSN: 2040-2503
DOI: 10.1039/c2md00317a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design of Chimeric Histone Deacetylase-

Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases †

✍ Mahboobi, Siavosh; Dove, Stefan; Sellmer, Andreas; Winkler, Matthias; Eichhorn, 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 621 KB

Discovery of novel 5-alkynyl-4-anilinopy

Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases

✍ Naoyuki Suzuki; Takeshi Shiota; Fumihiko Watanabe; Norihiro Haga; Takami Murashi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 624 KB

Antitumor and antiangiogenic effect of t

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

✍ Roque Diaz; Paul A Nguewa; Ricardo Parrondo; Carlos Perez-Stable; Irene Manrique 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 1019 KB

The growth inhibitory effect of lapatini

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

✍ Jin Won Kim; Hwang-Phill Kim; Seock-Ah Im; Soyeong Kang; Hyung Seok Hur; Young-K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 407 KB

2-Aroylindoles and 2-Aroylbenzofurans wi

2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors†

✍ Mahboobi, Siavosh; Sellmer, Andreas; Höcher, Heymo; Garhammer, Christian; Pongra 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 421 KB

A phase II study of lapatinib, a dual EG

A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer

✍ Whang, Young E.; Armstrong, Andrew J.; Rathmell, W. Kimryn; Godley, Paul A.; Kim 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 220 KB